Abrdn PLC Biolife Solutions Inc Transaction History

Abrdn PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 20, 2024	BUY	$16.95 - $25.07 $2.19 Million - $3.23 Million	128,969 New	128,969 $2.35 Million
Q4 2022 Feb 09, 2023	BUY	$16.95 - $25.07 $67,918 - $100,455	4,007 Added 3.21%	128,969 $2.35 Million
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $36,761 - $67,043	2,511 Added 2.05%	124,962 $2.84 Million
Q2 2022 Aug 05, 2022	SELL	$10.54 - $24.2 $101,953 - $234,086	-9,673 Reduced 7.32%	122,451 $1.73 Million
Q1 2022 May 04, 2022	BUY	$20.81 - $37.29 $37,957 - $68,016	1,824 Added 1.4%	132,124 $3.05 Million
Q2 2021 Aug 10, 2021	BUY	$29.51 - $44.62 $3.85 Million - $5.81 Million	130,300 New	130,300 $5.81 Million

192

44.7M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.22B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.